Phase 4 — Post-approval study. The treatment has been approved, but researchers continue monitoring it in a large population over time.
(13 sites) Belgium
Cliniques Universitaires Saint Luc (UCLouvain), Brussels University Hospital Gent (UZ Gent), Ghent France
Hospices Civils de Lyon - Hopital Femme Mère Enfant, Bron, Auvergne-Rhône-Alpes CHU de Toulouse - Hôpital des Enfants, Toulouse, Occitanie Bicetre University Hospital, Le Kremlin-Bicêtre, Île-de-France Region Germany
Children's University Hospital Essen, Essen University Hospital Hamburg-Eppendorf, Hamburg Italy
AO Ospedale PAPA GIOVANNI XXIII, Bergamo, Lombardy Istituto mediterraneo trapianti - ISMETT, Palermo, Sicily Netherlands
University Medical Center Groningen (UMCG), Groningen Spain
Hospital Universitairo Vall D'Hebron, Barcelona, Catalonia Hospital Universitario La Paz, Madrid